Healthcare Sector Momentum Trader (Remote, Funded) — Columbus, OH

A healthcare sector momentum trader at Maverick focuses on US healthcare equities — biotech catalysts, large pharma, medical devices, and the managed-care payer complex. The sector spans both highly volatile catalyst-driven small-caps and defensive large-cap names, which means a healthcare specialist runs two very different sub-strategies under one umbrella.

Columbus, OH: Columbus hosts the largest concentration of financial-services employment in the Midwest outside Chicago — Nationwide Insurance is headquartered here, JPMorgan has tens of thousands of employees, and the metro is one of the largest banking back-office centers in the country. Eastern Time alignment with the NYSE is clean, and the cost of living is among the lowest of any Eastern-Time US metro.

What you\'ll trade: Large pharma (JNJ, MRK, PFE, LLY) for stable trend trades and option liquidity, large biotech (AMGN, GILD, REGN) for fundamental-driven positioning, mid-cap biotech for catalyst trades around clinical data and FDA decisions, medical device names (ISRG, MDT) for steady momentum, and payers (UNH, ELV) for policy-driven moves.

Risk framework: Healthcare carries binary catalyst risk in biotech (one FDA decision moves a stock 40%), regulatory and political risk in payers and large pharma, and patent-cliff timing risk. Maverick limits biotech catalyst exposure to defined-risk structures and caps total sector concentration.

Why Maverick funds this role: Healthcare rewards domain expertise more than almost any other sector — the difference between a real clinical signal and noise isn\'t visible from price action alone. Maverick funds specialists who bring genuine sector knowledge, not generalists picking up healthcare names off a momentum screen.

Traders with a science or medical background — or who have done the work to understand it People who can read a clinical trial press release and assess the actual signal Candidates who already follow the FDA PDUFA calendar and major medical conferences Traders who can size catalyst trades for binary outcomes, not normal-distribution outcomes